These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 61642)

  • 1. [Possibilities in the treatment of advanced malignant lymphoma insensitive to the usual combination of cytostatics].
    Klener P; Donner L; Ort J
    Vnitr Lek; 1976 Aug; 22(8):760-6. PubMed ID: 61642
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
    Case DC
    J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Achievements in the treatment of leukemia and lymphoma].
    Berchenal J
    Klin Med (Mosk); 1973 Jun; 51(6):15-20. PubMed ID: 4590258
    [No Abstract]   [Full Text] [Related]  

  • 4. [New cytostatics in oncological therapy].
    Osieka R; Seeber S; Bruntsch U; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2468-74. PubMed ID: 4141307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advantages and hazards of combined chemotherapy in malignant lymphomas (author's transl)].
    Klener P; Donner L
    Sb Lek; 1978 Jun; 80(6):185-9. PubMed ID: 675144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)].
    Zittoun R; Barthélémy M; Bouchard M; Blanc CM; Bousser J; Bilski-Pasquier G
    Nouv Presse Med; 1977 Sep; 6(30):2669-71. PubMed ID: 909754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemostasis in patients with malignant non-Hodgkin's lymphoma and its changes during combined cytostatic therapy].
    Losonczy H; Nagy I; Miszlai Z
    Orv Hetil; 1982 Jan; 123(5):267-73. PubMed ID: 7063242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination chemotherapy in advanced malignant lymphoma with bleomycin, vincristine, adriamycin and prednisolone (author's transl)].
    Kurita S; Kamei Y; Murakami M; Oyama A; Goto T; Fukushima M; Ota K
    Rinsho Ketsueki; 1982 Jan; 23(1):61-7. PubMed ID: 6178855
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumors of the lymphatic system. Part II: therapy].
    Huber H; Hebenwarter W
    Acta Med Austriaca; 1977; 4(3):105-14. PubMed ID: 930542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Partial synchronization and cytostatic combination therapy of disseminated malignant lymphomas of the skin].
    Runne U; Bloch PH; Fischer R; Klein HO
    Hautarzt; 1980 Oct; 31(10):548-55. PubMed ID: 6778840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin in the treatment of the advanced, resistant and recurrent lymphomata.
    Garrett MJ; Smith JD
    Ir Med J; 1976 Feb; 69(3):67-70. PubMed ID: 67107
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of non-Hodgkin's lymphoma. Standard treatment.
    Bunting WL
    Ariz Med; 1974 Jun; 31(6):429-31. PubMed ID: 4135460
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication].
    Uszyński L; Maj S; Pawelski S
    Acta Haematol Pol; 1974; 5(2):153-7. PubMed ID: 4599294
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacotoxic aspects of antiblastic chemotherapeutic agents in hematological oncology].
    Cacciola E; Alessi M; Raimondo V
    Clin Ter; 1979 Nov; 91(4):339-50. PubMed ID: 540482
    [No Abstract]   [Full Text] [Related]  

  • 18. [ABP therapy in advanced non-Hodgkin's lymphoma resistant to VCP therapy].
    Kuraishi Y; Ozeki H; Takasaki N; Mashizu N; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K
    Rinsho Ketsueki; 1984 Sep; 25(9):1427-32. PubMed ID: 6084069
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Ryan DH
    Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
    García López J; Diumenjo MC; Argüelles MV; Marín P; Grañena A; Montserrat E; Rozman C
    Sangre (Barc); 1980; 25(6):1014-21. PubMed ID: 6164107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.